A Phase II Study of the Efficacy and Safety of the Novel Oral SHIP1 Activator AQX-1125 in Subjects with Moderate to Severe Interstitial Cystitis/Bladder Pain Syndrome
2016 ◽
Vol 196
(3)
◽
pp. 747-754
◽
Keyword(s):
Phase Ii
◽
Keyword(s):
2016 ◽
Vol 36
(4)
◽
pp. 1178-1186
◽
Keyword(s):
Keyword(s):
Keyword(s):
2016 ◽
Vol 48
(8)
◽
pp. 1215-1227
◽
Keyword(s):